Revenue of Sanofi 2006-2023

Sanofi is a global leader in healthcare and pharmaceuticals based in Paris, France. In 2023, Sanofi generated over 43 billion euros in revenues, the highest so far. In general, the company’s revenues have been increasing since 2006 when their revenues were 28.4 billion euros.

Sanofi’s company profile

Sanofi is a one of the world’s leading pharmaceutical companies and its subsidiaries include Genzyme and Sanofi Pasteur, to name a few. Sanofi is no longer ranked among the top 10 global pharmaceutical companies based on market capitalization (as of October 2023). However, the company is ranked among the top 10 global pharmaceutical companies based on its prescription sales.

Sanofi’s products and revenues

Sanofi works in several therapeutic sectors including diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, rare blood disorders, and vaccines. A majority of Sanofi’s revenues can be attributed to their pharmaceutical sector. Sanofi’s top pharmaceutical products, based on revenues include Dupixent, Lantus, and Lovenox . Lantus is a long-acting insulin for use in type I and type II diabetes. Sanofi also used to have an animal health sector but the business was sold to Boehringer Ingelheim in 2016.